IRIDEX CORP (IRIX)

↓ Download CSV

CIK 0001006045 · Nasdaq · Electromedical & Electrotherapeutic Apparatus

  • Sector Manufacturing
  • Incorporated DE
  • Fiscal year ends Jan 3

In fiscal 2026, IRIDEX CORP reported revenue of $52.67M. The company ran a net loss, with a net margin of -8.4% and a gross margin of 36.5%. It held $29.15M in total assets against $24.23M in total liabilities.

Key ratios (FY2026)

36.5%
Gross margin
-4.9%
Operating margin
-8.4%
Net margin
-90.1%
Return on equity
Metric (FY)2026202420232022202120192018201720162015
Revenue$52.67M$48.67M$51.87M$56.97M$36.35M$43.45M$42.60M$41.59M
Cost of Revenue$33.45M$29.17M$30.06M$31.60M$20.79M$25.51M$25.13M$26.09M$25.32M$21.41M
Gross Profit$19.23M$19.50M$21.81M$25.37M$15.56M$17.94M$17.47M$15.50M$20.84M$21.41M
Operating Income-$2.57M-$8.30M-$10.01M-$7.54M-$6.58M-$8.97M-$12.87M-$12.89M-$2.56M$2.59M
Net Income-$4.44M-$8.91M-$9.57M-$7.55M-$6.33M-$8.81M-$12.81M-$12.87M-$11.71M$10.04M
EPS (Diluted)$-0.26$-0.54$-0.59$-0.47$-0.46$-0.64$-1.05$-1.11$-1.15$0.97
Total Assets$29.15M$29.14M$34.44M$42.29M$27.97M$34.81M$41.67M$41.65M$48.14M$41.82M
Total Liabilities$24.23M$27.04M$24.91M$25.06M$10.60M$12.11M$11.71M$11.12M$8.98M$8.08M
Shareholders' Equity$4.92M$2.10M$9.52M$17.23M$17.37M$22.70M$29.96M$30.52M$39.16M$33.74M
Cash & Equivalents$6.03M$2.39M$7.03M$13.92M$11.63M$12.65M$21.19M$21.71M$23.75M$13.30M
Operating Cash Flow-$2.12M-$7.29M-$6.75M-$9.52M-$3.24M-$7.91M-$10.03M-$3.56M-$593.0K$4.01M
Capital Expenditures$143.0K$13.0K$109.0K$286.0K$97.0K$128.0K$440.0K$575.0K$1.06M$568.0K
Shares Outstanding16.93M16.44M16.13M15.94M13.84M13.71M12.20M11.55M10.17M10.36M